Cancer BiologybioRxivPreprint
CDK4/6 inhibition sensitizes breast cancer to NK cell therapy by inducing immune-interactive surface proteins
Yinchong Wang, Evdokiya Reshetnikova, Nar Bahadur Katuwal…·Anna E. Vilgelm
This paper shows CDK4/6 inhibitors make breast cancer cells more susceptible to NK cell therapy by increasing surface proteins that NK cells recognize.
DOI 10.64898/2026.04.19.719504